Clinical update: why PRP should be your first choice for injection therapy in treating osteoarthritis of the knee

CS Cook, PA Smith - Current reviews in musculoskeletal medicine, 2018 - Springer
Abstract Purpose of Review The purpose of this review is to update the reader on the current
applications of platelet-rich plasma (PRP) in the treatment of knee osteoarthritis (KOA). This …

Optimizing clinical use of biologics in orthopaedic surgery: consensus recommendations from the 2018 AAOS/NIH U-13 conference

CR Chu, S Rodeo, N Bhutani… - JAAOS-Journal of the …, 2019 - journals.lww.com
Concern that misinformation from direct-to-consumer marketing of largely unproven
“biologic” treatments such as platelet-rich plasma and cell-based therapies may erode the …

Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American Society of Interventional Pain Physicians (ASIPP) guidelines

L Manchikanti, AM Kaye, NN Knezevic… - Pain …, 2017 - scholarlycommons.pacific.edu
Background: Opioid use, abuse, and adverse consequences, including death, have
escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse …

Minimum information for studies evaluating biologics in orthopaedics (MIBO): platelet-rich plasma and mesenchymal stem cells

IR Murray, AG Geeslin, EB Goudie, FA Petrigliano… - JBJS, 2017 - journals.lww.com
Background: A comprehensive approach to the evaluation of biologic therapies for
musculoskeletal conditions is required to guide appropriate future use. Clinical studies …

Responsible, safe, and effective use of biologics in the management of low back pain: American Society of Interventional Pain Physicians (ASIPP) guidelines

A Navani, L Manchikanti, SL Albers… - Pain …, 2019 - scholarlycommons.pacific.edu
BACKGROUND: Regenerative medicine is a medical subspecialty that seeks to recruit and
enhance the body's own inherent healing armamentarium in the treatment of patient …

[PDF][PDF] Do regenerative medicine therapies provide long-term relief in chronic low back pain: a systematic review and metaanalysis

MD Jaya Sanapati… - Pain …, 2018 - painphysicianjournal.com
Background: Several cell-based therapies have been proposed in recent years the
management of low back pain, including the injection of medicinal signaling cells or …

Bone marrow concentrate (BMC) therapy in musculoskeletal disorders: evidence-based policy position statement of American Society of Interventional Pain …

L Manchikanti, CJ Centeno, S Atluri… - Pain …, 2020 - scholarlycommons.pacific.edu
BACKGROUND: The use of bone marrow concentrate (BMC) for treatment of
musculoskeletal disorders has become increasingly popular over the last several years, as …

International expert consensus on a cell therapy communication tool: DOSES

IR Murray, J Chahla, MR Safran, AJ Krych, DBF Saris… - JBJS, 2019 - journals.lww.com
Background: The lack of a standardized system for describing cell therapies acts as a barrier
to advancement in clinical and basic research and practice. The aim of this study was to …

Classification systems for platelet-rich plasma

LA Rossi, IR Murray, CR Chu… - The bone & joint …, 2019 - boneandjoint.org.uk
There is good scientific rationale to support the use of growth factors to promote
musculoskeletal tissue regeneration. However, the clinical effectiveness of platelet-rich …

Human organ-on-a-chip microphysiological systems to model musculoskeletal pathologies and accelerate therapeutic discovery

RE Ajalik, RG Alenchery, JS Cognetti… - … in Bioengineering and …, 2022 - frontiersin.org
Human Microphysiological Systems (hMPS), otherwise known as organ-and tissue-on-a-
chip models, are an emerging technology with the potential to replace in vivo animal studies …